Company profile

Arbutus Biopharma Corp Insider Trading

ABUS

Every SEC Form 4 insider trading filing for Arbutus Biopharma Corp (ABUS) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001447028
Filings
38
Insiders
16
Last filing
2026-06-08

Activity summary

No insider transactions in the last 30 days. The most recent was on June 8, 2026, when Beardsley Robert A bought 78,800 shares. 38 filings from 16 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q2 23 to Q2 26. Arbutus Biopharma Corp insiders are net sellers across the period shown.

Q2 23Q3 23Q1 24Q2 24Q3 24Q1 25Q3 25Q1 26Q2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $252K.

90 day insight

Over the last 90 days, Arbutus Biopharma Corp insiders bought $0 across 2 transactions with no open-market sales.

  • Most active insider: Beardsley Robert A with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 8, 2026Beardsley Robert AABUS
Award
78,800
Jun 8, 2026Sawhney RogerABUS
Award
78,800
Feb 2, 2026Nguyen TuanABUS
Award
73,500
Feb 2, 2026Nguyen TuanABUS
Award
188,400
Feb 2, 2026Androski LindsayABUS
Award
71,700

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=ABUS" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

McElhaugh Michael J.Interim President & CEO2 filings$102K
Hastings David CChief Financial Officer2 filings$95K
Sims KarenChief Medical Officer2 filings$74K
Manchester Keith S2 filings$2K
Naftzger J. ChristopherGeneral Counsel and CCO1 filing$37K

Institutional Ownership

Top 13F-HR holders of Arbutus Biopharma Corp as of 2026-06-30

↓ decreasing
Total reported AUM
$124.6M
QoQ change
-79.8%
Reporting period
2026-06-30
#1
State Street Corp
CIK 0000093751
$37.8M
7.9M shares
#2
BlackRock, Inc.
CIK 0002012383
$37.3M
7.8M shares
#3
BlackRock, Inc.
CIK 0002012383
$21.4M
4.4M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →